SCHEMBL725351

SCHEMBL725351

Nc1ncc(-c2ccccc2)[nH]1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MASP2 O00187 1/20 1.00
SCN2A Q99250 5/20 0.61
NPY5R Q15761 4/20 0.61
LTA4H P09960 1/20 0.54
HPGDS O60760 3/20 0.52
PDE10A Q9Y233 1/20 0.50
AOC3 Q16853 1/20 0.48
RAB9A P51151 1/20 0.46
SCN9A Q15858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13655229 0.96 MASP2 (0.92) MASP2SCN2ANPY5RLTA4HHPGDS
Trifluoroacetic Acid SCHEMBL16566514 0.85 MASP2 (0.72) MASP2SCN2ANPY5RLTA4HHPGDS
SCHEMBL13665045 0.84 MASP2 (0.72) MASP2SCN2ANPY5RLTA4HHPGDS
SCHEMBL4244858 0.84 MASP2 (0.71) MASP2SCN2ANPY5RLTA4HHPGDS
SCHEMBL4053949 0.83 MASP2 (0.70) MASP2SCN2ANPY5RLTA4HAOC3
Hydrochloric Acid SCHEMBL4243690 0.82 MASP2 (0.69) MASP2SCN2ANPY5RLTA4HHPGDS
SCHEMBL2768364 0.81 MASP2 (0.68) MASP2SCN2ANPY5RLTA4HHPGDS
SCHEMBL10979 0.81 MASP2 (0.68) MASP2SCN2ANPY5RLTA4HSCN9A
Hydrochloric Acid SCHEMBL4061012 0.81 MASP2 (0.68) MASP2SCN2ANPY5RLTA4HAOC3
SCHEMBL4056971 0.80 MASP2 (0.67) MASP2SCN2ALTA4HRAB9ASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270217-A1 IMIDAZ0[1,2-A]PYRIMIDINE-5(1 H)-ONES HAVING A COVALENT WARHEAD AT THE 3-POSITION AS WRN INHIBITORS INCYTE CORPORATION (US) 2025-08-28 US disclosed
US-9975857-B2 Inhibition of bacterial biofilms with imidazole-phenyl derivatives NORTH CAROLINA STATE UNIVERSITY (US) 2018-05-22 US disclosed
CN-102917775-B There is the PA membrane of the coating comprising polyalkylene oxide and imidazolium compounds DOW GLOBAL TECHNOLOGIES LLC (US) 2015-11-25 CN disclosed
EP-1932844-B1 CROSS-LINKED CYCLIC AMINE COMPOUNDS AND AGENTS FOR PEST CONTROL NIPPON SODA CO (JP) 2015-09-02 EP disclosed
US-20150183746-A1 INHIBITION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-PHENYL DERIVATIVES UNIV NORTH CAROLINA STATE (US) 2015-07-02 US disclosed
US-20150183746-A1 INHIBITION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-PHENYL DERIVATIVES UNIV NORTH CAROLINA STATE (US) 2015-07-02 US disclosed
US-9005643-B2 Inhibition of bacterial biofilms with imidazole-phenyl derivatives NORTH CAROLINA STATE UNIVERSITY (US) 2015-04-14 US disclosed
US-9005643-B2 Inhibition of bacterial biofilms with imidazole-phenyl derivatives NORTH CAROLINA STATE UNIVERSITY (US) 2015-04-14 US disclosed
US-8646616-B2 Composite membrane with coating comprising polyalkylene oxide and imidazol compounds DOW GLOBAL TECHNOLOGIES LLC (US) 2014-02-11 US disclosed
CN-102917775-A Polyamide membrane with coating comprising polyalkylene oxide and imidazol compounds DOW GLOBAL TECHNOLOGIES LLC 2013-02-06 CN disclosed
US-20110284454-A1 COMPOSITE MEMBRANE WITH COATING COMPRISING POLYALKYLENE OXIDE AND IMIDAZOL COMPOUNDS DOW GLOBAL TECHNOLOGIES LLC 2011-11-24 US disclosed
US-7816387-B2 β secretase inhibitor DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2010-10-19 US disclosed
US-20090270475-A1 INHIBITION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-PHENYL DERIVATIVES NORTH CAROLINA STATE UNIVERSITY (US) 2009-10-29 US disclosed
US-20090270475-A1 INHIBITION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-PHENYL DERIVATIVES NORTH CAROLINA STATE UNIVERSITY (US) 2009-10-29 US disclosed
US-20090198056-A1 Beta secretase inhibitor KISO, YOSHIAKI (JP) 2009-08-06 US disclosed
EP-1947098-A1 CYCLIC AMINE COMPOUNDS AND PEST CONTROL AGENT NIPPON SODA CO., LTD. (JP) 2008-07-23 EP disclosed
EP-1942101-A1 SECRETASE INHIBITOR Dainippon Sumitomo Pharma Co., Ltd. (JP) 2008-07-09 EP disclosed
WO-2008075109-A1 SUBSTITUTED PIPERIDINES HAVING PROTEIN KINASE INHIBITING ACTIVITY ASTEX THERAPEUTICS LIMITED (GB) 2008-06-26 WO disclosed
EP-1932844-A1 BRIDGED CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT NIPPON SODA CO., LTD. (JP) 2008-06-18 EP disclosed
WO-2000006552-A1 4-PHENYL- AND 4,5-DIPHENYLIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION SANOFI-SYNTHELABO (FR) 2000-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090198056-A1 Beta secretase inhibitor BACE1, BACE2, APP MASP2 1810/4885SCN2A 577/4885NPY5R 1400/4885
US-20250270217-A1 IMIDAZ0[1,2-A]PYRIMIDINE-5(1 H)-ONES HAVING A COVALENT WARHEAD AT THE 3-POSITION AS WRN INHIBITORS WRN, RECQL, BLM MASP2 3025/4885SCN2A 4344/4885NPY5R 4737/4885
US-20090270475-A1 INHIBITION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-PHENYL DERIVATIVES TFPI, O60361, PGLS MASP2 774/4885SCN2A 3744/4885NPY5R 4189/4885
US-20150183746-A1 INHIBITION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-PHENYL DERIVATIVES TFPI, O60361, PGLS MASP2 774/4885SCN2A 3744/4885NPY5R 4189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.